Immuron Limited (ASX:IMC)’s stock price was down 10% on Wednesday . The stock traded as low as A$0.14 ($0.10) and last traded at A$0.14 ($0.10), approximately 571,942 shares traded hands during trading. The stock had previously closed at A$0.15 ($0.11).

The stock’s 50 day simple moving average is A$0.13. The company has a market cap of $23.87 million and a price-to-earnings ratio of -4.22.

Immuron Company Profile (ASX:IMC)

Immuron Limited, a biopharmaceutical company, focuses on the research and development of immunomodulatory polyclonal antibodies for the treatment and prevention of various diseases through its oral immunoglobulins platform in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments.

Featured Article: What is a trade deficit?

Receive News & Ratings for Immuron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immuron and related companies with MarketBeat.com's FREE daily email newsletter.